Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum
Movement Disorders · 2026-08 · 41 (8) · 2178-2183
DOI: 10.1002/mds.70264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 10.03.2026. Verfasst von Finula I Isik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Parkinson Disease, Stearoyl-CoA Desaturase, Fatty Acids, Monounsaturated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Emerging evidence indicates that dysregulation of monounsaturated fatty acids (MUFAs), synthesized by the enzyme stearoyl‐coenzyme A desaturase (SCD), impacts on α‐synuclein pathology in the Parkinson's disease (PD) brain.
Objective
The objective of this study was to analyze SCD and MUFA‐enriched lipids in the periphery of patients with sporadic PD compared with healthy control subjects.
Methods
Serum SCD protein was quantified using enzyme‐linked immunosorbent assay in patients with PD (n = 40) and control subjects (n = 41). Lipidomic profiling was performed using liquid chromatography–mass spectrometry and LipidSearch software. Statistical analyses included Mann–Whitney U tests and Welch's t tests with false discovery rate (FDR) correction.
Results
SCD levels were higher in PD (mean = 1702 pg/ml) compared with control subjects (1158 pg/ml; P = 2.2 × 10 −4 ; Cohen's d = 0.73). Lipidomics showed elevated MUFA content in four lipid classes: methylphosphatidylcholine, phosphatidylcholine, dihexosylceramide, and triglycerides (FDR < 0.05).
Conclusions
Increased SCD and MUFA‐enriched lipids indicate altered membrane and sphingolipid metabolism in PD, consistent with central disease pathology, that present a potential for novel biomarker development for PD. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia.
- Bioanalytical Mass Spectrometry Facility, University of New South Wales, Sydney, New South Wales, Australia.
- Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
ORCID-Profile: Woojin Scott Kim
Zitieren
APA
Isik, F. I., Pickford, R., Chua, M., Lewis, S. J. G., Dzamko, N., & Kim, W. S. (2026). Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum. Movement Disorders, 41(8), 2178-2183. https://doi.org/10.1002/mds.70264
Vancouver
Isik FI, Pickford R, Chua M, Lewis SJG, Dzamko N, Kim WS. Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum. Movement Disorders. 2026;41(8):2178-2183. doi:10.1002/mds.70264
BibTeX
@article{Isik2026,
author = {Isik, Finula I and Pickford, Russell and Chua, Michelle and Lewis, Simon J G and Dzamko, Nicolas and Kim, Woojin Scott},
title = {Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum},
journal = {Movement Disorders},
year = {2026},
volume = {41},
number = {8},
pages = {2178--2183},
doi = {10.1002/mds.70264}
}
EUVIMED